Abstract:An intradural extramedullary spinal cord hemangioendothelioma at T10, T11 recurred twice and was irradiated after the third resection. This first reported case prompted a review of the neuropathology and natural history of this unusual tumor.
“…14) Intradural extramedullary spindle cell hemangioendothelioma involving the thoracic spinal cord recurred twice despite the benign histology and was irradiated after the third excision. 15) Immunohistochemical staining to identify cell proliferation markers, such as MIB-1 for Ki-67 antigen, as indicators of malignant behavior are useful in tumors of the central nervous system, particularly astrocytomas, but the implication…”
Section: Case Reportmentioning
confidence: 99%
“…Intradural extramedullary spindle cell hemangioendothelioma involving the thoracic spinal cord was treated by local radiotherapy using a limited field. 15) A tumor dose of 50 Gy in 28 fractions was given. The patient remained well with no evidence of recurrent tumor about 2 years after radiotherapy with good local control.…”
Section: Case Reportmentioning
confidence: 99%
“…However, the recommended radiation dose ranges from 20 to 50 Gy. 4,15) Our patient was treated with radiotherapy because of the significant residual tumor, high vascularity, and general unpredictable behavior of hemangioendothelioma. The patient demonstrated good neurological recovery following radiotherapy and is still doing well at present.…”
Section: Case Reportmentioning
confidence: 99%
“…9,16,24,27,31,33,34) However, intracranial or intraspinal involvement are infrequent. 2,6,12,13,15,29,30) We describe a case of intraspinal and intramedullary spindle cell hemangioendothelioma.…”
A 28-year-old Malay man presented with progressive paraparesis over a period of 6 months. Magnetic resonance imaging of the spine revealed a thoracic intramedullary spinal cord tumor at the T-7 level with homogeneous enhancement following intravenous gadolinium administration. Laminectomy and partial decompression of the tumor was performed. Histological examination of the tumor revealed features of spindle cell hemangioendothelioma. The patient was managed with limited field radiotherapy followed by systemic interferon therapy. Good neurological improvement was seen subsequently. The patient has survived 48 months with growth restraint at the primary site, although residual neurological deficit persists. Immunotherapy should be considered as a treatment modality for intramedullary hemangioendothelioma of the spinal cord after surgery and radiotherapy.
“…14) Intradural extramedullary spindle cell hemangioendothelioma involving the thoracic spinal cord recurred twice despite the benign histology and was irradiated after the third excision. 15) Immunohistochemical staining to identify cell proliferation markers, such as MIB-1 for Ki-67 antigen, as indicators of malignant behavior are useful in tumors of the central nervous system, particularly astrocytomas, but the implication…”
Section: Case Reportmentioning
confidence: 99%
“…Intradural extramedullary spindle cell hemangioendothelioma involving the thoracic spinal cord was treated by local radiotherapy using a limited field. 15) A tumor dose of 50 Gy in 28 fractions was given. The patient remained well with no evidence of recurrent tumor about 2 years after radiotherapy with good local control.…”
Section: Case Reportmentioning
confidence: 99%
“…However, the recommended radiation dose ranges from 20 to 50 Gy. 4,15) Our patient was treated with radiotherapy because of the significant residual tumor, high vascularity, and general unpredictable behavior of hemangioendothelioma. The patient demonstrated good neurological recovery following radiotherapy and is still doing well at present.…”
Section: Case Reportmentioning
confidence: 99%
“…9,16,24,27,31,33,34) However, intracranial or intraspinal involvement are infrequent. 2,6,12,13,15,29,30) We describe a case of intraspinal and intramedullary spindle cell hemangioendothelioma.…”
A 28-year-old Malay man presented with progressive paraparesis over a period of 6 months. Magnetic resonance imaging of the spine revealed a thoracic intramedullary spinal cord tumor at the T-7 level with homogeneous enhancement following intravenous gadolinium administration. Laminectomy and partial decompression of the tumor was performed. Histological examination of the tumor revealed features of spindle cell hemangioendothelioma. The patient was managed with limited field radiotherapy followed by systemic interferon therapy. Good neurological improvement was seen subsequently. The patient has survived 48 months with growth restraint at the primary site, although residual neurological deficit persists. Immunotherapy should be considered as a treatment modality for intramedullary hemangioendothelioma of the spinal cord after surgery and radiotherapy.
“…They most often have an indolent coarse [9,13], but can become painful and disfiguring [8,17]. Most lesions occur in the dermis and subcutaneous tissues, but have been found in the viscera, spinal cord, cervix, and oral cavity [26,36,40,41,43].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.